VU0405601 |
| カタログ番号GC70428 |
VU0405601は強力なKV 11.1チャネル活性化剤である。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 712325-30-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
VU0405601 (5 µM; pretreated for 30 min before 100 nm dofetilide) protects cardiac tissue from dofetilide -induced ventricular tachycardia[2].
VU0405601 (50 µM) can be used as a hERG agonist and increases test pulse and tail currents, increases the IC50 of dofetilide from 38.7 to 76.3 nm[2].
References:
[1]. Egly CL, et al. A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient KV11.1 (hERG) Variants. Mol Pharmacol. 2022 Apr;101(4):236-245.
[2]. Potet F, et al. Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias. J Biol Chem. 2012 Nov 16;287(47):39613-25.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *